Tobi Podhaler — Compare Prices at US & Canada Pharmacies
Compare real Tobi Podhaler prices at US and Canadian pharmacies, see official FDA uses and warnings, and find generic alternatives.
What is the out-of-pocket cost of Tobi Podhaler without health insurance?
Without insurance coverage, Tobi Podhaler can cost as much as $14,089.27 per refill. To reduce this expense, patients may explore pharmacy discount programs or manufacturer assistance programs that are often available for this medication.
What should I expect to pay for Tobi Podhaler if I have insurance?
The price of Tobi Podhaler under an insurance plan depends on your specific coverage level and the type of policy you hold. To find out your exact out-of-pocket cost, contact your pharmacy directly and ask them to calculate your copay or coinsurance. Comparing prices across different pharmacies can also help identify potential savings.
Is Tobi Podhaler covered by Medicare, and what is the cost?
Medicare typically does not provide coverage for Tobi Podhaler. Patients without alternative insurance may need to pay the full price, which can reach $14,089.27. Patient assistance programs, manufacturer rebates, or discount pharmacy networks may help lower the overall cost.
Does a generic version of Tobi Podhaler exist?
Tobi Podhaler is a brand-name medication manufactured by Novartis Pharmaceuticals Corporation. Currently, no generic formulation is available on the market.
Tobi Podhaler prices at US pharmacies
Tobi Podhaler — capsule, 28mg, qty 224
| Pharmacy | Retail price | With discount card |
|---|---|---|
| Kroger Pharmacy Lowest | $11466.07 | $11463.07 |
| Harris Teeter Pharmacy | $11466.07 | $11463.07 |
| Walgreens | $12030.32 | $12027.32 |
| Publix | $12101.89 | $12098.89 |
| Costco | $12380.14 | $12377.14 |
Tobi Podhaler prices at Canadian pharmacies
| Strength | Pharmacy | Per pill (USD) | Pack total |
|---|---|---|---|
| Default | SPFPharmacy.com | $16.39 | $11016.09 |
| Default | InhalersOnline.com | $16.45 | $11053.80 |
| Default | InhalersOnline.com | $16.55 | $3707.35 |
| Default | SPFPharmacy.com | $16.69 | $3739.58 |
| Default | InhalersOnline.com | $19.95 | $13406.19 |
| Default | InhalersOnline.com | $20.08 | $4497.90 |
Canada prices are converted to USD at time of collection and shown per tablet where available. Ordering from Canadian pharmacies is legal for personal use in most cases but subject to FDA/CBSA rules — see US vs Canada, explained.
What is Tobi Podhaler used for?
TOBI Podhaler delivers tobramycin, an aminoglycoside, directly to the lungs as a dry powder inhaled through a dedicated device, specifically to manage chronic Pseudomonas aeruginosa infection in cystic fibrosis patients 6 and older. Pseudomonas colonization is one of the central drivers of the progressive lung decline in CF, and suppressing it with regular inhaled antibiotic cycles is a cornerstone of standard CF care. Delivering tobramycin as an inhaled powder rather than IV or nebulized liquid concentrates the drug where it's needed — directly in the airways — while limiting the systemic absorption that drives the nephrotoxicity and ototoxicity boxed warnings on injectable aminoglycosides; those risks are much lower with inhaled dosing but aren't eliminated entirely, particularly with prolonged use.
TOBI Podhaler is dosed in repeating cycles: 28 days on, followed by 28 days off, rather than continuous daily use — a pattern designed based on clinical trial data showing this on-off rhythm controls Pseudomonas effectively while limiting the development of resistance that continuous exposure would accelerate. It's specifically not recommended for patients with very severe lung function impairment (FEV1 below 25% predicted) or those colonized with Burkholderia cepacia, since safety and efficacy weren't established in those populations during clinical development.
Because it's an aminoglycoside, combining it with other nephrotoxic, ototoxic, or neurotoxic drugs — including loop diuretics like furosemide, ethacrynic acid, or IV mannitol — is avoided, since these can compound aminoglycoside toxicity even when the primary drug is inhaled rather than injected. As with all aminoglycosides, it's contraindicated in patients with a known hypersensitivity to any drug in the class.
How Tobi Podhaler works
Inhaled directly into the lungs
The dry powder capsule is loaded into the Podhaler device and inhaled, delivering tobramycin straight to the airways where Pseudomonas colonizes.
Binds to the bacterial ribosome
Tobramycin attaches to the bacterial ribosome and disrupts the machinery bacteria use to build proteins.
Suppresses the infection
With protein synthesis disrupted, Pseudomonas growth is suppressed, helping preserve lung function during 28-day treatment cycles.
Typical dosage forms & strengths
| Use | Typical adult dose | Form |
|---|---|---|
| Cystic fibrosis with Pseudomonas aeruginosa (6+) | 4 capsules (112 mg) inhaled twice daily, 28 days on / 28 days off | Inhalation capsule (Podhaler device) |
General reference dosing from the FDA label — not personalized advice. Your prescribed dose may differ based on your infection, kidney function, age, and weight. Always follow your prescriber's instructions.
Related & alternative drugs
Warnings & interactions
This is a summary of the official FDA label text, not personalized medical advice. It does not list every possible interaction or side effect. Always tell your prescriber and pharmacist about every medicine and supplement you take.
Common, usually mild
- Cough or hoarseness
- Altered taste
- Dry mouth or throat irritation
Serious — seek care promptly
- Hearing loss or ringing in the ears
- Coughing up blood or chest tightness
- Signs of kidney injury (changes in urination)
- Signs of a severe allergic reaction
Contraindications
4 CONTRAINDICATIONS TOBI Podhaler is contraindicated in patients with a known hypersensitivity to any aminoglycoside. Known hypersensitivity to any aminoglycoside ( 4 )
Notable drug interactions
| Drug / substance | What can happen |
|---|---|
| Other nephrotoxic, ototoxic, or neurotoxic drugs (e.g., loop diuretics, IV mannitol) | Concurrent or sequential use avoided due to compounded toxicity risk |
Pregnancy & breastfeeding
8.1 Pregnancy Risk Summary Aminoglycosides can cause fetal harm. Published literature reports that use of streptomycin, an aminoglycoside, can cause total, irreversible, bilateral congenital deafness when administered to a pregnant woman [ Warnings and Precautions (5.5) ] .
Frequently asked questions
How much does Tobi Podhaler cost without insurance?
Is there a generic version of Tobi Podhaler?
What drug class is Tobi Podhaler in?
Learn more about Tobi Podhaler
In-depth answers to common Tobi Podhaler questions, fact-checked against the sources cited in each.
What is Tobi Podhaler and how is it used?
Tobi Podhaler is an inhaled antibiotic designed to treat lung infections in people with cystic fibrosis. The condition causes patients to produce thick, sticky mucus that blocks airways and creates an environment where bacterial infections thrive. This medication halts bacterial growth in the lungs. The drug comes as a powder inside capsules that are loaded into a specialized inhaler device. Patients inhale the powder orally, typically twice per day at 12-hour intervals, taking roughly two to six minutes per dose. Do not exhale into the mouthpiece during use. The standard treatment course lasts 28 days, followed by a 28-day break; your doctor will determine whether to repeat the cycle. The mouthpiece should be cleaned and dried after each use, while the inhaler itself should never be washed with water—keep it dry and stored in its protective case. Replace the inhaler with a new one each week.
What side effects can occur with Tobi Podhaler?
Common side effects include hoarseness, cough, dry mouth, voice changes, difficulty speaking, and altered taste perception. Most people tolerate the medication well, but report any persistent or worsening effects to your doctor. Serious side effects, though uncommon, can include hearing loss or ringing in the ears, dizziness, changes in urination frequency, coughing up blood, and chest tightness or wheezing. Seek immediate medical attention if you experience any of these symptoms. This is not an exhaustive list of possible side effects; discuss any concerns with your healthcare provider.
Page info
Prices last checked 2026-08-21. Reviewed against FDA and DailyMed official sources — see our review process. Not a substitute for professional medical advice.
Kami Kim, M.D., Infectious Diseases, Global Health